| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.7 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.021 | 0.7 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |